INSL5 | Insulin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
HOXB13 | Homeobox B13 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MS4A12 | Membrane-spanning 4-domains, subfamily A, member 12 | Predicted membrane proteins
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
GAL3ST2 | Galactose-3-O-sulfotransferase 2 | Predicted secreted proteins
| | | | | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | | | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CDX1 | Caudal type homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | Predicted intracellular proteins
| | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
TPH1 | Tryptophan hydroxylase 1 | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Group enriched |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CEACAM7 | Carcinoembryonic antigen-related cell adhesion molecule 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | | | | Group enriched |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
NXPE2 | Neurexophilin and PC-esterase domain family, member 2 | Predicted intracellular proteins
| | | | | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SLC26A2 | Solute carrier family 26 (anion exchanger), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
LGALS4 | Lectin, galactoside-binding, soluble, 4 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
SATB2 | SATB homeobox 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
VIP | Vasoactive intestinal peptide | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CES3 | Carboxylesterase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EYS | Eyes shut homolog (Drosophila) | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |